Temporomandibular Joint Disorders
Conditions
Keywords
TMD, temporomandibular, dextrose, prolotherapy
Brief summary
Dysfunction of the jaw, associated with pain in the jaw or about the jaw in the face can be quite long lasting and debilitating. Dextrose injection with a small needle has been notably helpful in preliminary studies in reducing pain and improving jaw function. This randomized trial will compare dextrose injection with sterile water injection for temporomandibular(jaw) dysfunction, also known as TMD.
Detailed description
Longitudinal studies of subjects with temporomandibular dysfunction show a general pattern of symptom diminishment, especially in the elderly. However studies out to 2-8 years show residual symptoms in many and nearly 25% with unabated symptoms. Dextrose injection has been utilized empirically for many years and a marked reduction in pain and luxation after intra-articular and pericapsular dextrose injection has been reported in a recent RCT. However, small study size and lack of a non injection control have prevented any definitive conclusions as the additional efficacy of including dextrose in the injectate. The mechanism of action of dextrose injection was originally thought to be via a brief stimulation of the inflammatory cascade with resultant production of growth factors. However, non-inflammatory dextrose effects on growth factor production have been demonstrated, and, more recently, dextrose has been found to treat neurogenic inflammation (pain from upregulation of the TRPV1 receptor on peptidergic nerves). This has the theoretical benefit of reducing pain, regardless of the status and position of the intraarticular cartilage or degree of degenerative change of the TMD. The primary goal of this study is to evaluate the ability of dextrose injection versus saline injection to reduce pain and improve functional complaints referable to the temporomandibular joint.
Interventions
Injection at 0, 1, and 2 months of 1 ml of a solution consisting of 20% dextrose and 0.2% lidocaine.
OTHERInjection of 1 ml of 0.8 Sterile water /0.2% lidocaine
Injection at 0, 1, and 2 months of 1 ml of a solution consisting of 0.8 sterile water and 0.2% lidocaine
Sponsors
K. Dean Reeves, M.D.
Chisel Peak Medical Clinic
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
19 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
more than 3 month history of : * Facial Pain NRS rating \> 5/10 * Jaw symptom rating \> 5/10 * Jaw function issues seen on examination
Exclusion criteria
* Any potential acute dental issue * Rheumatic inflammatory disease * Chronic intake of NSAIDs or corticosteroids. * Pain in other body location worse than jaw pain * Pain 10/10 in other body location.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline to 3 months in Numerical Rating Scale (NRS) for Jaw Pain | 3 Months | TMJ injection of 20% dextrose will result in significantly more pain relief at 3 months than injection of .2% lidocaine. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline to 3 months in Numerical Rating Scale (NRS) for Jaw Dysfunction. | 3 Months | TMJ injection of 20% dextrose will result in significantly more improvement in Jaw Dysfunction at 3 months. Jaw dysfunction is rated based on the worst of the following: Chewing difficulty, jaw tension or stiffness, fatigue with eating, or grinding noises |
| TMJ injection of 20% dextrose will result in sustainable improvement in Jaw Pain to 1 year follow-up. | 1 year | TMJ injection of 20% dextrose will result in sustainable improvement in Jaw Pain to 1 year follow-up. |
Countries
Canada
Outcome results
None listed